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ABSTRACT 
Present communication was aimed to investigate the effect 
of excipients on buoyancy and drug release properties from 
the floating tablets. Gastroretentive floating tablets were 
developed by the wet granulation method using hydroxypropyl 
methylcellulose (HPMC K4M), carbopol 934P and carbopol 
971P as a rate controlling polymers and crospovidone as a 
dissolution enhancer. Sodium bicarbonate and citric acid 
were used as a gas generating agent. PVP K30 was used as 
granulating agent. The effect of formulation variables on tablet 
performance was examined quantitatively based on buoyancy 
properties, swelling behavior and drug release profiles. The 
drug release mechanism was investigated using mathematical 
models. It was found that HPMC/carbopol matrices at 1:1 ratio 
with crospovidone and sodium bicarbonate gave sustained and 
better drug release profile upto 24 h when compared to HPMC 
or carbopol matrices alone. The mechanism of drug release was 
found to be anomalous non Fickian.
Keywords: Buoyancy, floating drug delivery, gastroretentive, 
ofloxacin, swelling index.
INTRODUCTION
Oral route has variable and versatile physiological conditions, 
which enables development of oral formulations that can 
selectively release the medicament for optimal therapeutic 
benefit (1). Conventional drug delivery systems are unable 
to maintain the drug concentration within the therapeutic 
range. In case of conventional therapeutic systems, it is often 
necessary to administer the dosage form several times a day 
which may result in significant fluctuation in plasma drug 
concentration. The basic rationale for the development of 
gastroretentive controlled release drug delivery system is 
to maintain the drug concentration within the absorption 
window, reducing the number of administrations and to 
improve the efficacy of drugs (2). Floating drug delivery 
systems are less prone to the gastric emptying, resulting in 
reduced intra and inter-subject variability (3). While the 
system is floating, the drug is released in a controlled manner 
from the delivery device. The released drug will have whole 
surface area of the upper segment of gastrointestinal tract 
for absorption, and thus the absorption of the drug can be 
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enhanced (2). Various gastroretentive dosage forms such as 
bioadhesive or mucoadhesive systems, dual working systems, 
high-density systems, expandable systems, floating systems, 
magnetic systems, and superporous hydrogel systems have 
been designed to improve the oral bioavailability of drugs 
by increasing the gastric residence time of dosage form. 
Considerable attention has been given for the development 
of a gastroretentive controlled release system using buoyancy 
mechanism. Floating systems do not bind with gastric 
mucosal surfaces and reduce the safety problems associated 
with mucoadhesive systems. Drug delivery systems based 
on gastroretention mechanisms are not suitable for those 
drugs which cause gastric lesions such as, non-steroidal anti-
inflammatory agents (4).
Ofloxacin, poorly soluble drug in alkaline pH with pKa of 
7.1, exhibits pH dependent solubility profile in digestive fluid 
(5). Requirement of acidic pH for the optimum absorption 
of ofloxacin reflects its ideal candidature for development of 
floating drug delivery system. Based on the above facts, the 
present study was aimed to investigate the effect of various 
excipients on floating tablet properties which will increase 
the gastric residence time and release drug in the proximal 
gastrointestinal region.
MATERIALS AND METHOD
Materials 
Ofloxacin was received as a gift sample from Wockhardt 
Ltd., Aurangabad, India. Hydroxypropyl methylcellulose 
(HPMC K4M) was obtained as a gift sample from Colorcon 
Asia Pvt Ltd., Goa, India. Crospovidone was obtained as a 
gift sample from Signet Chemicals, Mumbai, India. Carbopol 
934P and 971P were obtained as a gift sample from Lubrizol, 
Cleveland, USA. Sodium bicarbonate, citric acid, PVP K30, 
magnesium stearate and talc were purchased from SD Fines, 
Mumbai, India.
Methods
Fabrication of floating tablets 
Floating tablets were prepared by wet granulation method. 
Weighed amounts of various polymers and 400 mg of the 
drug were thoroughly mixed and passed through sieve no. 40 
(Table 1 and Table 2). Wet granulation was done using PVP 
K30 solution in isopropyl alcohol (5% w/v). The wet mass 
was passed through sieve no. 20 and dried in a hot air oven 
at 40°C. Dried granules were lubricated using magnesium 
stearate and talc and compressed into caplet sized tablets 
using 19.2 X 9.4 mm size punch in a rotary tablet press 
(Rimek Mini Press 1, Karnavati, Ahmedabad, India).
Table 1. Composition of ofloxacin floating tablets.
Composition
(mg/tablet)
Formulation code
FH1 FH2 FH3 FH4 FH5 FH6 FH7 FH8 FH9 FH10 FH11
Ofloxacin 400 400 400 400 400 400 400 400 400 400 400
HPMC K4 M 100 150 200 250 200 200 200 200 200 200 200
Sodium bicarbonate 30 30 30 30 50 70 100 30 30 30 30
Crospovidone 20 20 20 20 20 20 20 20 20 50 100
Citric Acid - - - - - - - 20 40 - -
Table 2. Composition of ofloxacin floating tablets.
Composition
(mg/tablet)
Formulation code
FC1 FC2 FC3 FC4 FC5 FC6 FC7 FC8 FC9 FC10 FC11 FC12
Ofloxacin 400 400 400 400 400 400 400 400 400 400 400 400
HPMC K4 M - - - - - - 100 100 100 100 70 70
Sodium bicarbonate - - 30 30 50 50 30 30 30 30 30 30
Crospovidone - - - - - - - - 50 50 50 50
Carbopol 934 P 200 - 200 - 200 - 100 - 100 - 130 -
Carbopol 971 P - 200 - 200 - 200 - 100 - 100 - 130
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Evaluation of floating tablets
Determination of assay
Six tablets from each batch were weighed and powdered 
using a glass mortar and pestle without any material 
loss. Powder equivalent to the average tablet weight was 
accurately weighed, transferred into a 100 ml volumetric 
flask and dissolved in 0.1 N HCl (pH 1.2). For complete 
drug release, the mixture was agitated for 24 h at 37 ± 0.5°C. 
After 24 h, the sample was filtered and analyzed using a 
UV spectrophotometer (UV 3000+, LabIndia Instruments, 
Mumbai, India) at 293 nm after suitable dilution.
Physical characterization
The fabricated tablets were characterized for weight variation, 
hardness using Monsanto hardness tester, friability using USP 
friabilator (EF-2, Electrolab, Mumbai, India) and thickness 
using a digital screw-gauge micrometer (Mityato, Japan).
Determination of density
The tablet density was determined by displacement method 
using benzene as a displacing medium. A plethysmometer 
was employed to measure the tablet density. The instrument 
was calibrated using benzene (density 0.8723 g/cc) for its 
volumetric capacity. Briefly, the benzene was filled up to 
the mark in capillary of instrument. Subsequently, five 
tablets of known weight were dropped in the wide mouth 
of plethysmometer. The system was kept undisturbed for 1 
min to displace air by benzene from the tablets pores. The 
displacement in benzene volume was noted. Knowing the 
weight and volume occupied by the tablets, density of five 
tablets was determined (6).
Determination of buoyancy properties
The time taken by the tablet to emerge on surface of the 
medium (floating lag time) and duration of the tablet to 
constantly remain on surface of the medium (total floating 
time) were investigated using USP 24 type II dissolution 
apparatus at 37±0.5°C in 900 ml of 0.1N HCl. Total six 
measurements were taken from each batch (n=6) (7).
Determination of swelling index
Ofloxacin floating tablets were weighed individually (W0) 
and placed in 900 ml of dissolution medium (0.1 N HCl). 
The temperature was maintained at 37±0.5°C. On saturation, 
the tablets were removed and swollen tablet weight (Wt) was 
determined. The percentage swelling index was calculated by 
(8): 
In vitro release study
The release of ofloxacin from floating tablets was studied 
using USP dissolution apparatus II. The release studies were 
carried out in 900 ml of 0.1N HCl (pH 1.2) at 100 rpm. The 
temperature was maintained at 37±0.5°C. Aliquots (5 ml) 
were withdrawn at predetermined time intervals of every 1 h 
for the first 4 h followed by every 2 h interval till 12th h and 
then at every 4 h interval till 24th h. The sink condition was 
maintained by replacing an equivalent amount of dissolution 
medium after each sampling. The samples were analyzed 
using a UV spectrophotometer (UV 3000+, LabIndia 
Instruments, Mumbai, India) at 293 nm. The sampling was 
done in triplicate from each batch (9).
Analysis of drug release kinetics
To study the drug release kinetics, the dissolution data 
were plotted in various kinetic models: zero order as the 
cumulative amount of drug released against time, first order 
as the log cumulative percentage of drug remaining against 
time. The drug release mechanism was determined using 
Higuchi’s model as a cumulative percentage of drug released 
against the square root of time (10) and Korsmeyer model 
as a log percentage of drug released against log time. The in 
vitro drug release data were statistically analyzed by two-way 
analysis of variance (ANOVA). The p value of <0.0001 was 
considered as statistically significant.
RESULTS AND DISCUSSIONS
Assay
The drug content in all the formulations was in the range of 
99.11 to 101.23%. This ensured the uniformity of drug within 
the tablet.
Physical characterization
Weight variation data indicates no significant difference 
in individual tablet weight from the average weight. Tablet 
hardness was observed within the range of 3.1±0.134 to 
4.2±0.152 kg/cm2. Friability of all the formulations was below 
1%, which indicates good mechanical strength of the tablets 
(Table 3).
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Tablet density
Apparent tablet density was found to be in the range of 
0.651±0.090 to 0.989±0.049 g/cm3, except formulation FC1 
and FC2. High densities of formulation FC1 and FC2 might 
be due to the fact that carbopol is less porous in nature and 
thus the tablet had a higher bulk density than other polymers 
used. The density of tablets was decreased by an increased 
amount of HPMC, crospovidone and sodium bicarbonate. 
The variation in tablet density might be due to the difference 
in the porosity of polymers used.
Buoyancy properties
All the formulations (except formulation FC1 and FC2) had 
a short floating lag time due to the presence of sodium 
bicarbonate. Formulation FC1 and FC2 had more than 45 
min floating lag time and showed practically no floating 
behavior. An increase in the sodium bicarbonate amount 
from 0 mg to 30 mg in carbopol matrices reduced the floating 
lag time. Decrease in floating lag time was observed with 
the incorporation of HPMC K4M and crospovidone to the 
carbopol matrices (formulation FC7 to FC12). After an initial 
floating lag time, all the tablets were floating uniformly for a 
prolonged period of time. This may be due to the entrapment 
of carbon dioxide gas within the tablet gel matrix formed 
by the hydration of HPMC, carbopol and crospovidone. 
Higher buoyancy duration of carbopol containing tablets 
may be due to the less swelling of carbopol and entrapment 
of CO2 gas in the carbopol gel layer. More floating lag time of 
carbopol containing tablets may be due to the higher density 
of carbopol.
Swelling index
The swelling nature of polymer affects the dissolution behavior. 
Thus, in the present investigation, the swelling behavior of 
tablets was determined using water uptake approach. The 
Table 3. Physical properties of ofloxacin floating tablets.
Formulation
code
Density
(g/cm3)
Floating
lag time 
(sec)
Floating
Duration 
(h)
Thickness
(mm)
Weight
(mg)
Friability
(%)
Hardness
(kg/cm2)
Assay
(%)
FH1 0.717±0.086 35.3±3.6 12.0±2.5 5.124±0.008 560.1±0.912 0.75 3.5±0.133 99.23
FH2 0.780±0.099 43.0±5.0 12.0±3.5 5.278±0.018 612.2±0.230 0.38 3.5±0.095 99.11
FH3 0.753±0.046 39.2±4.4 12.0±2.6 5.424±0.006 662.1±1.821 0.64 3.0±0.125 99.44
FH4 0.812±0.024 48.1±6.7 16.0±1.7 5.672±0.005 715.8±3.654 0.67 3.6±0.113 99.17
FH5 0.686±0.087 32.9±4.1 20.0±1.5 5.462±0.014 665.1±2.734 0.49 4.1±0.109 98.17
FH6 0.734±0.073 25.6±3.2 20.0±1.7 6.198±0.067 755.2±4.167 0.45 3.8±0.165 99.34
FH7 0.769±0.101 12.0±2.0 20.0±4.0 6.377±0.081 785.8±1.891 0.56 3.2±0.093 99.20
FH8 0.651±0.090 15.7±1.9 12.0±3.5 5.367±0.011 632.3±2.781 0.54 4.2±0.152 99.50
FH9 0.690±0.085 17.0±2.0 12.0±2.0 6.016±0.028 735.7±3.254 0.63 4.0±0.096 99.42
FH10 0.816±0.034 39.2±4.8 16.0±3.2 5.987±0.033 695.6±2.672 0.69 3.6±0.126 99.99
FH11 0.844±0.029 45.6±6.3 12.0±2.0 6.156±0.021 745.4±3.123 0.81 3.1±0.134 101.21
FC1 1.321±0.151 >2700 - 5.209±0.041 612.9±4.176 0.54 3.6±0.101 99.79
FC2 1.335±0.101 >2700 - 5.267±0.034 612.2±3.654 0.68 3.3±0.091 101.10
FC3 0.983±0.96 360.0±30.0 24.0±0.6 5.367±0.069 642.6±2.176 0.45 3.6±0.138 99.57
FC4 0.971±0.045 420.0±50.0 24.0±1.6 5.398±0.081 642.4±3.271 0.31 4.1±0.104 99.23
FC5 0.936±0.181 120.0±30.0 24.0±1.8 5.467±0.014 665.8±1.832 0.88 3.3±0.161 99.14
FC6 0.942±0.086 130.0±30.0 24.0±1.3 5.492±0.024 665.3±4.427 0.73 4.2±0.144 99.34
FC7 0.894±0.093 60.0±40.0 24.0±0.5 5.376±0.038 642.1±4.246 0.48 3.9±0.091 99.29
FC8 0.910±0.036 68.0±10.2 24.0±1.1 5.362±0.061 642.9±3.551 0.63 3.8±0.141 99.92
FC9 0.875±0.071 55.2±8.4 24.0±1.0 5.856±0.074 695.3±2.731 0.59 3.1±0.069 99.88
FC10 0.893±0.097 51.0±5.4 24.0±0.4 5.826±0.018 695.3±1.105 0.71 3.4±0.121 101.23
FC11 0.991±0.102 70.8±6.6 24.0±0.5 6.163±0.009 745.3±1.90 0.77 3.7±0.113 98.99
FC12 0.989±0.049 74.6±5.4 24.0±1.0 6.198±0.015 745.4±3.241 0.59 3.6±0.133 99.78
Data represents mean ± SD (n=6)
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polymer in tablet matrix undergoes simultaneously swelling, 
dissolution, and diffusion into the bulk medium, resulting in 
reduction of strength and erosion of the matrix (11, 12). In the 
present study, complete swelling was achieved at the end of 8 
h (Figure 1 A and Figure 1 B). An increase in tablet swelling 
was observed with an increase in HPMC concentration 
(formulation FH1 to FH4). Significant increase in swelling of 
the tablet was observed with an addition of crosspovidone. 
When the concentration of crospovidone was increased from 
20 mg (formulation FH3) to 100 mg (formulation FH11), the 
tablet swelling was increased from 216.89% to 259.34%. It was 
due to the controlled and high swelling of crospovidone in 
the presence of water soluble hydrophilic polymer. Carbopol 
matrices showed limited changes in the percentage swelling 
when compared to HPMC matrices. Pure carbopol matrices, 
formulations FC1 and FC2 showed 52.76% and 53.87% 
swelling, respectively. Addition of sodium bicarbonate in 
carbopol matrices increased swelling of tablets. This might be 
due to the entrapment of CO2 gas in the carbopol gel layer. 
Carbopol/HPMC matrices containing sodium bicarbonate 
showed an increased swelling as compared to the formulations 
containing pure carbopol. Such swelling behavior could be 
due to the hydrophilic nature of the HPMC and entrapment of 
gas within the gel matrix. With the addition of crospovidone 
in Carbopol/HPMC matrices (formulation FC9 and FC10), 
higher percentage swelling was observed. Further increase 
in Carbopol concentration in Carbopol/HPMC matrices 
decreased the percentage swelling due to decrease in 
hydrophilic polymer (HPMC) concentration.
Figure 1. Effect of various processing parameters on swelling 
behavior of tablets after 8 h, formulations FH1 - FH11 (A) and 
formulations FC1 - FC12 (B).
In vitro release study
Ideally, an extended-release tablet should release the the 
drug in a predetermined and reproducible manner. In vitro 
dissolution studies were aimed to investigate the effect of gas 
generating agent and polymer type and concentration on the 
release behavior of ofloxacin from the floating tablets.
Effect of HPMC concentration on drug release
Tablets prepared using HPMC K4M alone showed sustained 
drug release for 12 to 20 h. The drug release from tablets 
containing HPMC K4M (100 mg) showed 99.97% drug 
release at the end of 12 h. The more sustaining effect was 
observed with an increase in HPMC K4M concentration from 
100 mg to 250 mg. Percentage cumulative drug release after 
4 h was found to be 53.2%, 50.32%, 42.53% and 36.66% from 
formulation FH1, FH2, FH3 and FH4, respectively (Figure 2). 
This effect on drug release profile might be due the increase 
in resistance of gel layer caused by greater intimate contact 
between the particles of HPMC which results in decreased 
mobility of insoluble drug particles in swollen matrices, 
which led to decreased release (13).
Figure 2. The effect of HPMC concentration on drug release from 
HPMC matrices in 0.1 N HCl, pH 1.2 at 37°C (mean ± SD, n=3).
Effect of effervescent agents on drug release
Sodium bicarbonate and citric acid act as effervescent agents 
that generate CO2 gas when the tablet comes in contact with 
an aqueous acidic medium. CO2 gas entrapped into the 
matrices of water soluble polymers and leads to up word 
movement of tablets thus tablets floats on acidic medium. 
As the concentration of sodium bicarbonate increased in 
formulations FH3 (30 mg), FH5 (50 mg), FH6 (70 mg) and 
FH7 (100 mg), the drug release was found to be decreased at 
the end of 4 h (Figure 3 A). This effect may be due to the pH 
dependent solubility profile of ofloxacin. Ofloxacin is more 
soluble in acidic medium as compared to alkaline medium. 
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Increase in concentration of sodium bicarbonate created an 
alkaline micro-environment, thus more sustained effect was 
observed. The results are in concordance with the finding of 
earlier researchers (14). Effect of citric acid is shown in figure 
3 (B). An increase in the concentration of citric acid led to 
the more burst drug release as compared to the formulation 
without citric acid. Formulations containing citric acid FH8 
(20 mg) and FH9 (40 mg) showed faster drug release at 4 h 
that was 53.17% and 56.81%, respectively compared to FH3 (0 
mg) 42.53%. But, citric acid led to the dimensional stability 
problems of tablets, thus citric acid was not use in the further 
formulations. 
The addition of 30 mg of sodium bicarbonate to pure carbopol 
matrices led to increase in the floating properties of the 
tablets and increase in the drug release. As the concentration 
of sodium bicarbonate increased from 0 mg (FC1 and FC2) 
to 30 mg (FC3 and FC4), the percent cumulative drug release 
was increased from 41.75% and 41.53% to 63.33% and 63.02, 
respectively at the end of 12 h. Further increase in sodium 
bicarbonate concentration led to decrease the percentage 
cumulative drug release. This might be due to the alkaline 
micro-environment caused by the increased concentration of 
sodium bicarbonate. At the end of 12 h the drug release was 
found to be 59.54% and 58.93% for the formulation FC5 and 
FC6, respectively (Figure 3 C).
Figure 3. The effect of effervescent agents concentration on 
drug release in 0.1 N HCl, pH 1.2 at 37°C (mean ± SD, n=3). 
Effect of sodium bicarbonate concentration on drug release 
from HPMC matrices (A), effect of citric acid on drug release 
from HPMC matrices (B), effect of sodium bicarbonate 
concentration on drug release from carbopol matrices (C).
Effect of crospovidone on drug release
Crospovidone is a superdisintegrant, when comes into 
contact with an aqueous medium swell immediately to at 
least twice its original volume. Carbopol and HPMC K100M 
were used simultaneously to form a gel network due to which 
the swollen mass of crospovidone restrained in the tablet and 
the tablet does not disintegrate. The effect of crospovidone on 
drug release profile is presented in figure 4 (A). It is evident 
that as the concentration of crospovidone increased from 
20 mg (FH3) to 50 mg (FH10), the percent cumulative drug 
released was increased from 31.83% to 46.65% at the end of 4 
h. In case of formulation containing 100 mg of crospovidone 
(FH11), the percent cumulative drug release was found 
to be 53.56% at the end of 4 h. As the concentration of 
crospovidone increased, the water uptake capacity of the 
formulation increased which could have contributed to 
increase in the drug release from the formulation and also 
leads to the dimensional instability of the tablet. Based on 
such findings, less than 50 mg of crospovidone is suggested 
for the formulation of HPMC based floating tablet.
Crospovidone improved the drug release profile from the 
carbopol matrix due to its swelling properties. The addition 
of 50 mg crospovidone to the formulations FC9 and FC10 the 
drug release was increased as compared to the formulations 
FC7 and FC8 and it was found to be 99.92% and 99.95% at the 
end of 24 h (Figure 4 B).
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Figure 4. Effect of crospovidone concentration on drug 
release in 0.1 N HCl, pH 1.2 at 37°C (mean ± SD, n=3). Effect 
of crospovidone concentration on drug release from HPMC 
matrices (A), effect of crospovidone concentration on drug 
release from carbopol matrice (B).
Effect of carbopol on drug release
In order to sustain the drug release for 24 h, carbopol was 
added due to its high viscosity and swelling properties. Pure 
carbopol matrices (formulation FC1 and FC2) sustained the 
drug release for 24 h and cumulative percentage drug release 
at the end of 24 h was found to be 41.75% (FC1) and 41.53% 
(FC2).
Increase in carbopol concentration in carbopol-HPMC 
combination matrices leads to decrease in drug release 
(Figure 5). The cumulative percentage drug release was 
found to be 87.39% (FC11) and 89.08% (FC12) as compared 
to 99.92% (FC9) and 99.95% (FC10) after 24 h due to the 
formation of gel layer, which retarded the release of the 
drug. Change in carbopol grade did not affect the cumulative 
percentage drug release.
Figure 5. The effect of carbopol concentration on drug 
release in 0.1 N HCl, pH 1.2 at 37°C (mean ± SD, n=3).
Effect of carbopol-HPMC combination on drug release
It was found that, alone carbopol retarded the drug release 
due to early disappearance of CO2 bubbles. But, in case of 
formulations containing Carbopol and HPMC combination 
resulted in swelling, no disappearance CO2 bubbles and 
prolonged drug release due to the hydrophilic nature of 
HPMC was observed. In formulation FC7 and FC8 carbopol 
and HPMC K4M were used in 1:1 ratio. The cumulative 
percentage drug release was increased in formulation FC7 
(85.71%), FC8 (86.43%) as compared to FC3 (41.75%) and 
FC4 (41.53%) at the end of 24 h (Figure 6). 
Figure 6. The effect of carbopol/HPMC combination on 
drug release in 0.1 N HCl, pH 1.2 at 37°C (mean ± SD, n=3).
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Drug release kinetics
Three major rate controlling mechanisms for controlled 
or sustained release formulations are diffusion, swelling 
and disintegration/ erosion (2). The drug release from the 
polymeric system is generally followed by the diffusion 
process and best described by Fickian diffusion mechanism. 
But, in case of formulations containing polymers having 
swelling property, relaxation of polymer chains, ambition 
of water, causing the polymers to swell and changing them 
from initial glassy to rubbery state can also describe the drug 
release behavior (15).
The drug dissolution from pharmaceutical dosage forms 
that do not disaggregate and release the drug slowly can be 
described by zero order kinetics.
Q1 = Q0 + K0t 
where Q1 is the amount of the drug dissolved in time t, Q0 is 
the initial amount of drug in solution, K0 is the zero-order 
rate constant expressed in units of concentration/time and t 
is the time in h. A graph of concentration against time would 
yield a straight line with a slope equal to K0 and intercept the 
origin of the axes.
The first order model is used to describe absorption and 
elimination of drugs. Following equation expresses this 
model:
log Q1 = log Q0 + (K1t /2.303) 
where Q1 is the amount of drug released in time t, Q0 is the 
initial amount of drug in the solution and K1 is the first order 
release constant. In case of drug release following first order 
kinetics, a plot of the logarithm of drug released against time 
will be linear.
Higuchi developed several models to study the release of 
water soluble and low soluble drugs incorporating in semi 
solid and or solid matrices. The Higuchi’s model is expressed 
as (16).
Ft = KHt1/2
where KH is the Higuchi’s dissolution constant reflecting the 
design variables of the system and t is the time in h. Hence, 
the drug release rate is proportional to the reciprocal of the 
square root of time. Higuchi described drug release as a 
diffusion process based on the Fick’s law, square root time 
dependent.
To evaluate the mechanism of drug release from ofloxacin 
floating tablets, the dissolution data were plotted according 
to the Korsmeyer equation as log cumulative percentage 
of drug released against log time, and the exponent n was 
calculated through the slope of the straight line.
Mt/M∞ = atn
where Mt/M∞ is the fractional solute release, t is the release 
time, K is a kinetic constant characteristic of the drug/ 
polymer system, and n is an exponent that characterizes 
the release mechanism. If the value of n is less than or equal 
to 0.45, it corresponds to a Fickian diffusion mechanism, 
if the value is greater than 0.45 and less than 0.89, it 
corresponds to non-Fickian transport, if the value is equal 
to 0.89, it corresponds to Case II (relaxational) transport, 
and if it is above 0.89 the release mechanism is super case 
II transport.
In the present investigation, with an increase in HPMC 
concentration in HPMC matrices, the drug release followed 
zero order release profile (formulation FH2 – FH4). When 
the higher correlation coefficient values are considered, the 
released data from the most HPMC based formulations 
seem to fit better with zero order and Korsmeyer model. The 
released data from carbopol based formulations seem to fit 
better with first order and Higuchi model. Further, the n values 
obtained from the Korsmeyer kinetic model suggested that 
the drug release mechanism was shifted from Fickian to non-
Fickian direction with an increased amount of gas generating 
agent. These findings are not in the support of Khan et al. 
(17). In case of tablets containing HPMC alone at the highest 
concentration of gas generating agent (formulation FH7), the 
n value obtained from Korsmeyer kinetic model was 1.0408, 
which indicated super case II transport mechanism of drug 
release. In HPMC-Carbopol matrices, the best fit with the 
highest determination r2 coefficients was shown by both 
the first order and Higuchi models which indicate the drug 
release via diffusion mechanism. The n values of 0.5421 to 
0.7438 indicated that the drug release mechanism was non-
Fickian or anomalous diffusion. The kinetic data obtained 
from in vitro release study are presented in table 4.
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On application of two-way ANOVA, a significant difference 
was observed in the in vitro drug release profiles among the 
various formulations (FH1 - FH11 and FC1 - FC12) at 95% 
confidence interval (p<0.0001). Since, the calculated F value 
is much larger than the table value, the null hypothesis of 
equal population means was rejected and concluded that 
there is a (statistically) significant difference between the 
dissolution profiles. This supports the role of polymer type 
and concentration in controlling the drug release and also 
indicates the validity of the developed formulations (Table 5). 
All the calculations were performed using GraphPad Prism 
v5.1 (GraphPad Prism Software Inc., San Diego, California).
Table 4. Kinetics of in vitro release data from floating tablets of ofloxacin.
Formulation Code Zero order (r2) First order (r2)
Higuchi Model Korsmeyer model
(r2) n r2
FH1 0.8872 0.9055 0.9647 0.7094 0.9683
FH2 0.9116 0.8930 0.9785 0.6488 0.9866
FH3 0.9219 0.8926 0.9516 0.8835 0.9739
FH4 0.9633 0.8897 0.9568 0.6738 0.9761
FH5 0.8782 0.9884 0.9597 0.7231 0.9734
FH6 0.9068 0.9168 0.9377 0.8655 0.9657
FH7 0.9532 0.8549 0.9228 1.0408 0.9877
FH8 0.8928 0.8926 0.9742 0.5979 0.9840
FH9 0.9334 0.8281 0.9675 0.5229 0.9766
FH10 0.8933 0.8719 0.9719 0.6016 0.9836
FH11 0.9268 0.9636 0.9682 0.8329 0.9720
FC1 0.8751 0.9167 0.9709 0.7173 0.9320
FC2 0.8834 0.9230 0.9718 0.7437 0.9358
FC3 0.8154 0.8865 0.9532 0.6100 0.9370
FC4 0.8092 0.8758 0.9455 0.5911 0.9338
FC5 0.8332 0.9060 0.9657 0.6092 0.9314
FC6 0.8427 0.9100 0.9674 0.6252 0.9425
FC7 0.8559 0.9811 0.9776 0.5814 0.9620
FC8 0.8518 0.9808 0.9739 0.5769 0.9638
FC9 0.8461 0.9824 0.9722 0.5456 0.9705
FC10 0.8325 0.9747 0.9667 0.5421 0.9641
FC11 0.8601 0.9557 0.9673 0.5931 0.9765
FC12 0.8642 0.9696 0.9721 0.5744 0.9805
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CONCLUSION
The effervescent-based floating drug delivery is a promising 
approach to achieve in vitro buoyancy by using the gel-
forming polymer HPMC K4M, carbopol and gas-generating 
agent sodium bicarbonate. But, addition of crospovidone in 
the HPMC and carbopol matrices improves the drug release 
profile. From the swelling and drug release profile it was found 
that HPMC/carbopol matrices with crospovidone and sodium 
bicarbonate showed the best release upto 24 h. From the analysis 
of data, it was found that the drug was diffused out from the 
tablets. Mechanism of drug release was found to be anomalous 
non Fickian drug release.
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Midede kalış süresini uzatan yüzen tabletlerin 
özelliklerini etkileyen yardımcı maddeler üzerinde bir 
araştırma 
ÖZ
Bu çalışma kapsamında, yüzen tabletlerin bileşiminde yardımcı 
madde olarak kullanılan bazı bileşenlerin tabletin mide sıvısının 
yüzeyinde kalabilme ve ilaç salım özelliklerini nasıl etkilediği 
araştırılmıştır. Midede kalış süresini uzatan yüzen tabletler, yaş 
granülasyon yöntemiyle; hidroksipropilmetilselüloz (HPMC 
K4M), ilaç salım hızını kontrol eden polimerler-karbopol 934P 
ve karbopol 971P ve çözünürlüğü arttırıcı olarak krospovidon 
kullanılarak hazırlanmıştır. Efervesans etki amacıyla sitrik 
asit ve sodyum bikarbonat kullanılmıştır. Granülasyon ajanı 
olarak PVP K30 kullanılmıştır. Formülasyon değişkenlerinin 
tabletlerin özelliklerine etkileri nicel yöntemlerle; mide sıvısı 
üzerinde kalabilme özellikleri, şişme özelliği ve ilaç salım 
özellikleri yönünden incelenmiştir. İlaç salım mekanizması 
matematiksel modelleme yöntemi kullanılarak çalışılmıştır. 
HPMC/karbopol matrisi 1:1 oranında kullanıldığında ve 
krospovidon ile sodyum bikarbonat varlığında elde edilen 24 
saatlik ilaç salım profilinin HPMC ya da karbopol’ün tek başına 
kullanıldığı formülasyonlara kıyasla daha başarılı olduğu tespit 
edilmiştir. İlaç salım mekanizması ise Fick’e uymayan salım 
olarak belirlenmiştir.
Table 5. Results of two way ANOVA on the release profiles of ofloxacin from different formulations (FH1- FH11 and FC1- FC12).
Source of variation Sum of square Degree of freedom Mean square Calculated F Tabulated F
     Formulations (FH1- FH11)
CSS 4246 10 424.6 20.08 1.91
RSS 104700 9 11630 550.2 1.96
ESS 1903 90 21.15
      Formulations (FC1- FC12)
                    CSS                      23870   11    2170 56.94 1.85
                    RSS                      55410   10    5541 145.4 1.90
                    ESS                      4193   110    38.12
CSS Column sum of squares, RSS Raw sum of squares, ESS Error sum of squares
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